ABOUT THE PROCEDURE
Use of Plasmolifting technology in surgery provides wide range of local therapeutic effects, improves results and allows significant reduction of treatment duration and improvement of the quality of life.
OPERATING MODE AND FEATURES OF USE OF PLASMOLIFTING™ TECHNOLOGY IN SURGERY
Use of Plasmolifting technology (Plasmolifting™) in surgery involves same name treatment, on which platelet autologous plasma (PAP) is injected into nidus area and surrounding soft tissues.
Platelet autologous plasma contains not less than 6 growth promoting substances. Due to this plasma property, Plasmolifting treatment is efficiently used in holistic treatment regimen for surgical pathology, providing acceleration of regeneration processes in damaged tissues. PAP injections favor inflammation arresting, protect against allergy, prevent fibrosis formation and adhesion, and activate genesis of healthy blood vessels.
Introduction of autologous plasma injections produced using Plasmolifting technology (Plasmolifting™) into treatment regimen allows minimization of administered medicaments or even discontinuation of those, decreasing patient organism toxicity. In addition, treatment favors reduction of treatment duration by 2-3 times.
- second-degree burns;
- third-degree a burns;
- third-degree b a burns;
- preparation for skin graft (flap grafting);
- persistent wounds;
- trophic ulcer:
– of venous etiology;
– of combined etiology;
– in the setting of diabetic foot;
– post-traumatic and postsurgical cicatricial trophic ulcers;
– decubitus ulcer.
EFFECT FROM THE PROCEDURE:
- reversal of inflammation;
- elimination of hypoxia in tissues;
- pain syndrome reversal;
- acceleration and optimization of regenerative processes in tissues;
- improving quality of life;
- increasing a disease remission.